185 related articles for article (PubMed ID: 37572568)
1. Meta-Analysis of the Outcomes of Peri-Device Leak After Left Atrial Appendage Closure.
Mostafa MR; Eid MM; Abuelazm M; Al-Abdouh A; Najim M; Hassan AR; El-Sakka AA; Renjithal SLM; Malik MA; Mohamed S; Balmer-Swain M; Paul TK; Goldsweig AM
Am J Cardiol; 2023 Oct; 204():325-332. PubMed ID: 37572568
[TBL] [Abstract][Full Text] [Related]
2. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Peri-Device Leaks on Ischaemic Stroke/Transient Ischaemic Attack/Systemic Embolism after Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.
He YG; Yang SH; Xu L; Wang Y; Qin XT; Chen PP; Zhao YJ
Cardiology; 2023; 148(6):581-592. PubMed ID: 37459844
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
Bing S; Chen RR
Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
[TBL] [Abstract][Full Text] [Related]
6. Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
Dukkipati SR; Holmes DR; Doshi SK; Kar S; Singh SM; Gibson D; Price MJ; Natale A; Mansour M; Sievert H; Houle VM; Allocco DJ; Reddy VY
J Am Coll Cardiol; 2022 Aug; 80(5):469-483. PubMed ID: 35902169
[TBL] [Abstract][Full Text] [Related]
7. Peri-device leakage not CHA2DS2-VASc is associated with post-left atrial appendage closure cardiovascular event.
Huang PS; Chiu FC; Cheng HL; Hsu JC; Chua SK; Chu CY; Lin TT; Chen JJ; Tsai CT
J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106688. PubMed ID: 36095860
[TBL] [Abstract][Full Text] [Related]
8. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
[TBL] [Abstract][Full Text] [Related]
9. Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.
Price MJ; Ellis CR; Nielsen-Kudsk JE; Thaler D; Gupta N; Koulogiannis K; Anderson JA; Gage R; Lakkireddy D
JACC Cardiovasc Interv; 2022 Nov; 15(21):2127-2138. PubMed ID: 36357016
[TBL] [Abstract][Full Text] [Related]
10. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
Takeda K; Tsuboko Y; Iwasaki K
Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
[TBL] [Abstract][Full Text] [Related]
11. Left atrial appendage occlusion using the LAmbre device in atrial fibrillation patients with a history of ischemic stroke: 1-Year outcomes from a multicenter study in China.
Bangash AB; Li Y; Huang W; Zhong J; Zheng H; Zhang D; Zeng A; Wang R; Zhao W; Wang M; Zhao Y; Yu L; Liu Q; Jiang R; Jiang C; Zhang J
Pacing Clin Electrophysiol; 2023 Dec; 46(12):1478-1483. PubMed ID: 37943004
[TBL] [Abstract][Full Text] [Related]
12. Value of detecting peri-device leak and incomplete endothelialization by cardiac CT angiography in atrial fibrillation patients post Watchman LAAC combined with radiofrequency ablation.
Zhao MZ; Chi RM; Yu Y; Wang QS; Sun J; Li W; Zhang PP; Liu B; Feng XF; Zhao Y; Mo BF; Chen M; Zhang R; Gong CQ; Yu YC; Li YG
J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2655-2664. PubMed ID: 34428342
[TBL] [Abstract][Full Text] [Related]
13. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis.
Tan BE; Wong PY; Lee JZ; Tan NY; Rao M; Cheung JW
Curr Probl Cardiol; 2022 Nov; 47(11):101335. PubMed ID: 35872052
[TBL] [Abstract][Full Text] [Related]
14. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure?
Zender N; Weise FK; Bordignon S; Herrmann E; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
Europace; 2019 Oct; 21(10):1502-1508. PubMed ID: 31230078
[TBL] [Abstract][Full Text] [Related]
16. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcome of patients with left atrial appendage closure in China: a single-center experience.
Zhang J; Li C; Zhou L; Sang C; Li S; Ma C
BMC Cardiovasc Disord; 2024 Feb; 24(1):108. PubMed ID: 38355458
[TBL] [Abstract][Full Text] [Related]
18. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
Holmes DR; Doshi SK; Kar S; Price MJ; Sanchez JM; Sievert H; Valderrabano M; Reddy VY
J Am Coll Cardiol; 2015 Jun; 65(24):2614-2623. PubMed ID: 26088300
[TBL] [Abstract][Full Text] [Related]
19. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation.
Jiang H; Koh TH; Vengkat V; Fei G; Ding ZP; Ewe SH; Jappar I; Lim ST; Yap J
Am J Cardiol; 2023 Aug; 200():135-143. PubMed ID: 37321026
[TBL] [Abstract][Full Text] [Related]
20. Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL Studies.
Brouwer TF; Whang W; Kuroki K; Halperin JL; Reddy VY
J Am Heart Assoc; 2019 Dec; 8(23):e013525. PubMed ID: 31752643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
